Table 1 Transcript levels of genes related to fibrosis and inflammation in mice.

From: Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease

Target gene

Sham

BDL

Oil

CCl4

Ad-Null

Ad-VHL

Ad-Null

Ad-VHL

Ad-Null

Ad-VHL

Ad-Null

Ad-VHL

Glut1

1.00 ± 0.31

0.39 ± 0.19

39.58 ± 7.52*

12.45 ± 3.88

1.00 ± 0.25

0.51 ± 0.20

6.78 ± 1.93*

0.63 ± 0.35

LDHA

1.00 ± 0.20

0.99 ± 0.33

9.26 ± 2.54*

7.79 ± 2.51

1.00 ± 0.34

0.85 ± 0.34

6.35 ± 1.72*

1.52 ± 0.43

PDK1

1.00 ± 0.26

0.94 ± 0.26

9.05 ± 3.07*

2.48 ± 0.57

1.00 ± 0.23

0.80 ± 0.25

8.00 ± 1.78*

3.00 ± 0.49

EPO

1.00 ± 0.26

0.33 ± 0.11

40.76 ± 6.18*

17.50 ± 4.02

1.00 ± 0.26

0.42 ± 0.07

28.67 ± 7.02*

3.04 ± 0.84

Collagen-1α

1.00 ± 0.32

0.48 ± 0.11

21.99 ± 1.61*

7.01 ± 0.63

1.00 ± 0.19

0.80 ± 0.12

14.79 ± 1.54*

5.30 ± 0.75

TGF-β1

1.00 ± 0.29

0.47 ± 0.11

14.36 ± 2.50*

7.65 ± 1.62

1.00 ± 0.24

0.80 ± 0.20

6.38 ± 1.08*

2.77 ± 0.64

TIMP-1

1.00 ± 0.32

0.73 ± 0.23

5.14 ± 0.57*

1.73 ± 0.34

1.00 ± 0.32

0.93 ± 0.10

4.28 ± 0.58*

1.51 ± 0.27

PAI-1

1.00 ± 0.25

0.72 ± 0.21

9.11 ± 1.54*

4.73 ± 0.95

1.00 ± 0.22

0.78 ± 0.17

6.27 ± 0.74*

2.60 ± 0.54

PDGF-B

1.00 ± 0.20

0.77 ± 0.22

7.70 ± 1.20*

2.87 ± 0.56

1.00 ± 0.27

0.98 ± 0.17

5.30 ± 0.67*

1.97 ± 0.53

TNF-α

1.00 ± 0.21

0.60 ± 0.12

15.20 ± 2.10*

6.84 ± 1.58

1.00 ± 0.27

0.79 ± 0.15

4.46 ± 0.60*

2.02 ± 0.39

MCP-1

1.00 ± 0.27

1.07 ± 0.24

7.14 ± 1.09*

2.31 ± 0.41

1.00 ± 0.21

0.63 ± 0.12

4.31 ± 0.67*

1.31 ± 0.22

MIP-1β

1.00 ± 0.30

0.80 ± 0.31

11.69 ± 1.51*

4.31 ± 0.95

1.00 ± 0.20

0.66 ± 0.18

6.17 ± 0.94*

2.84 ± 0.38

MIP-2

1.00 ± 0.26

0.39 ± 0.08

8.81 ± 1.17*

3.56 ± 0.71

1.00 ± 0.21

0.70 ± 0.16

7.73 ± 0.91*

2.64 ± 0.52

  1. *p < 0.001 vs Ad-Null + sham or Ad-Null + Oil, p < 0.001 vs Ad-Null + BDL or Ad-Null + CCl4.